A randomised, open labelled clinical trial to investigate synovial mechanisms determining response-resistance to rituximab versus tocilizumab in rheumatoid arthritis patients failing TNF inhibitor therapy
No Thumbnail Available
Issue Date
2019
Our author(s)
Gendi, N.
Dasgupta, B.
Department
Keywords
Language
English
Publisher
John Wiley and Sons Ltd
ISSN
2326-5205
eISSN
ISBN
Type
Conference paper
Citation
Humby, F., Buch, M. H., Durez, P., Lewis, M., Bombardieri, M., Rizvi, H., Kelly, S., Fosatti, L., Hands, R., Giorli, G., Mahto, A., Montecucco, C., Lauwerys, B., Romao, V., Pratt, A., Bugatti, S., Ng, N., Rivellese, F., Ho, P., Bellan, M., Congia, M., Verschueren, P., Sainaghi, P. P., Gendi, N., Dasgupta, B., Cauli, A., Reynolds, P., Canete, J., Moots, R. J., Taylor, P., Edwards, C., Isaacs, J., Sasieni, P., Fonseca, J. E., Choy, E. & Pitzalis, C. 2019. A randomised, open labelled clinical trial to investigate synovial mechanisms determining response-resistance to rituximab versus tocilizumab in rheumatoid arthritis patients failing TNF inhibitor therapy. Arthritis and Rheumatology, 71, (Supplement 10) 5180-5183.